Latest Lung Cancer Updates from ESMO 2014 – Advances in ALK Positive NSCLC by Dr. Sunil Verma
Browsing: Acute Lymphoblastic Leukemia
Dr. James Brugarolas, M.D., Ph.D. Kidney Cancer Program Leader Associate Professor of Internal Medicine & Developmental Biology University of Texas…
Bernard J. Escudier, M.D. accepts the 2014 Eugene P. Schonfeld Award at the Kidney Cancer meeting in Chicago
Dr. Hiral D. Parekh, M.D. discusses Cost Analysis of an Initial Observation Approach in Metastatic Renal Cell Carcinoma at the…
Dr. Laurence Albiges, M.D., Ph.D. discusses Differential expression of c-MET between primary and metastatic sites in clear cell Renal Cell…
Dr. Andre P. Fay, M.D. discusses Whole-Exome Sequencing Predicting Two Extreme Phenotypes of Response to VEGF-targeted Therapies in Patients with…
Dr. Joshua Lang, M.D., M.S. discusses Development of Pharmacodynamic Biomarkers in Circulating Renal Cancer Cells at the Kidney Cancer meeting…
Dr. Andrew G. Winer discusses Tumor Purity and Immune Cell Infiltration as a Prognostic Risk Predictor for Clear Cell Renal…
Dr. David Kwiatkowski talks about The mTOR signaling pathwayWho responds to rapalogs and why? at the Kidney Cancer meeting in…
Dr. Harriet Kluger, M.D.Associate Professor Yale Cancer Center discusses The Met Pathway as a Target in RCC at the Kidney…
Dr. David F. McDermott discusses Immune correlates and long-term follow-up of a Phase Ia study of MPDL3280A, an engineered PD-L1…
Dr. Thai Ho, M.D., Ph.D.Mayo Clinic Arizona discusses The Evolving Role of Chromatin and Epigenetics in RCC at the Kidney…
Dr. Toni K. Choueiri discusses Risk Factors and a Model to Predict Toxicity-related Treatment Discontinuation in Patients with Metastatic Renal…
Dr. Sumanta K. Pal, MD;1 Min Li, PhD;2 Xiwei Wu, PhD;3 Paul Frankel, PhD2 Â 1Department of Medical Oncology, City…
Dr. Georg A. BjarnasonDivision of Medical OncologySunnybrook Odette Cancer CentreAssociate Professor, Faculty of Medicine, University of Toronto discusses Dose Reduction or…
Dr. David I. Quinn MBBS (Hons) PhD FRACP FACP Associate Professor of Medicine Chief, Section of GU Medical Oncology Division…
Dr. Frede Donskov, M.D., PhD Chair, Danish Renal Cancer Group, DARENCA Aarhus University Hospital Denmark discusses Toxicity as a Biomarker…
Suzanne L. Topalian of Johns Hopkins University School of Medicine Sidney Kimmel Comprehensive Cancer Center discusses Biomarkers for PD-1 checkpoint…
Dr. Drew Pardoll of Johns Hopkins discusses Basic Concepts and Future Horizons in Cancer Immunotherapy at the Kidney Cancer Meeting…
Elizabeth R. Plimack MD MS Director, Genitourinary Clinical Research Associate Professor, Department of Hematology/Oncology discusses Combination immunotherapy + VEGF targeted…
M. Dror Michaelson, MD PhD MGH Cancer CenterBoston, MA discusses how TKIs are the Optimal Front-Line mRCC Treatment
Dr. Michael B. Atkins, MD Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center discusses the Optimal Front-Line Treatment for mRCC
Toni K. Choueiri, MD Clinical Director and Kidney Cancer Center Director The Lank Center for Genitourinary Oncology Dana-Farber Cancer Institute…
Ari Hakimi MD Assistant Professor Urologic Oncology Affiliate Department of Computational Biology MSKCC presents Genomic Characterization of Sarcomatoid Clear Cell…
Jianjun Gao, MD, PhD Department of Genitourinary Oncology MD Anderson Cancer Center presents Molecular Characterization of Renal Medullary Carcinoma at…
Gabriel G. Malouf, MD, PhD Assistant professor Department of medical oncology Pitié-Salpêtrière Hospital, Paris, France discusses Translocation Renal Cell Carcinomas:…
Laurence Albiges, MD, PhD Lank Center for Genitourinary Oncology presents Papillary Renal Cell Carcinoma at the Kidney Cancer Association meeting…
James Hsieh MD PhD MSKCC Translational Kidney Cancer Research Program (TKCRP) presents13thIKCS Chicago Rare Kidney Cancer:Chromophobe RCC at the Kidney…
Michael L. Blute Sr. MD Chief Urology MGH Walter S. Kerr Jr. Professor of Surgery Harvard Medical School presents Case…
Michael L. Blute Jr of MD Anderson presents the Recurrence After Surgery in Non-metastatic RCC with Thrombus; Risk Factors From…
Stephen H. Culp, M.D., Ph.D. Assistant Professor, Department of Urology discusses Cytoreductive Nephrectomy at the Kidney Cancer Association meeting in…
Sarah P. Psutka MD Fellow in Urologic Oncology Mayo Clinic, Rochester, MN presents the Latest On IVC Tumor Thrombus at…
Jonathan Coleman, MD Memorial Sloan-Kettering Cancer Center Weill – Cornell University Medical College presents Kidney Cancer Management:The Role of Lymph…
At the iwNHL 2014, Prof Francesco D’Amore (Aarhus University, Aarhus, Denmark) interviews Dr Elaine Jaffe (National Cancer Institute, Maryland, USA)…
Thomas D. Atwell, MD presents Ablation of larger and recurrent tumors at the Kidney Cancer Association meeting in Chicago 2014
R. Houston Thompson, MD of the Mayo Clinic presents NCCN and AUA GUIDELINES FOR RCC: DO THEY EFFECTIVELY CAPTURE RECURRENCES…
Joel Prince of The University of Wisconsin School of Medicine and Public Health presents Patient and Tumor Characteristics Predict Indeterminate…
Jose A. Karam, MD Assistant Professor Department of Urology MD Anderson presents Locally Advanced RCC: Neoadjuvant Targeted Therapy
Tony Finelli MD, MSc, FRCSC GU Site Lead, Princess Margaret Cancer Center GU Lead, Cancer Care Ontario Associate Professor, University…
Lara Barbara – Breast Cancer Survivor NSHOA Treats Patients with Chemo and Hugs brought to you by The Community Oncology…
Michael Murray – Primary Goal for Everyone at NSHOA is Patient Care brought to you by The Community Oncology Alliance…
Dr. Ron Burkes commenting on the results of the Lux-Lung8 Trial from ESMO 2014
Dr. Natasha Leighl, lead study author, on the newsiest results on the activity of pembrolizumab in lung cancer
Dr. Edith Perez speaking on the expanded results of the ALTTO breast cancer trial
Dr. Sunil Verma providing a comprehensive update on the latest lung cancer updates from ESMO 2014
Don Marx – Care for Today, Research for Tomorrow brought to you by The Community Oncology Alliance (COA) and The…
Dr. Tewari at ESMO 2014 on latest advanced cervical cancer therapies
Dr. Teresa Petrella and Dr. Catalin Mihalcioiu speaking on combination therapies in melanoma.
Mark Levine – CFO North Shore Hematology Oncology Focused on Patient Care brought to you by The Community Oncology Alliance…
Immuno-Oncology: Shaping the Present, Transforming the Future and Raising the Bar in Oncology – from Best of ASCO Canada 2014